SCP
AVNS

Sandhill Capital Partners’s Avanos Medical AVNS Stock Holding History

Sandhill Capital Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-397,462
Closed -$17.3M – 78
2019
Q2 		$17.3M Buy
397,462
+23,204
+6% +$993K 2.2% 26
2019
Q1 		$16M Buy
374,258
+28,299
+8% +$1.27M 2.23% 23
2018
Q4 		$15.5M Buy
345,959
+8,082
+2% +$423K 2.56% 20
2018
Q3 		$23.1M Buy
+337,877
New +$21.7M 3.43% 10

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sandhill Capital Partners's AVNS Position: Q3 2019 in Review

Sandhill Capital Partners sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 397,462 shares — an estimated $17.3M sold.

Sandhill Capital Partners first reported a position in AVNS in Q3 2018 and held it in 4 quarters. The position peaked at $23.1M in Q3 2018. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

  • Sandhill Capital Partners reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
  • Sandhill Capital Partners sold 397,462 Avanos Medical shares in Q3 2019, an estimated $17.3M.
  • Sandhill Capital Partners first reported a position in Avanos Medical in Q3 2018 and held it in 4 quarters.
  • Sandhill Capital Partners's Avanos Medical position peaked at $23.1M in Q3 2018.
  • 290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Sandhill Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.